Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter

Cancer Letters

Volumn 283, Issue 1, 2009, Pages 20-28

  Liao, Zhengkai ^a   Huang, Chenghu ^a   Zhou, Fuxiang ^a   Xiong, Jie ^a   Bao, Jie ^a   Zhang, Hongyan ^a   Sun, Wenjie ^a   Xie, Conghua ^a   Zhou, Yunfeng ^a  

^a Hubei Cancer Clinical Study Center   (China)

Author keywords

Gene therapy; HRP IAA; hTERT promoter; Laryngeal squamous cell carcinoma; Radiation tolerance

Indexed keywords

HORSERADISH PEROXIDASE; INDOLEACETIC ACID; PLASMID DNA; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE THERAPY; TUMOR NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FEMALE; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; HUMANS; IN SITU NICK-END LABELING; LARYNGEAL NEOPLASMS; MICE; MICE, NUDE; PROMOTER REGIONS, GENETIC; RADIATION TOLERANCE; RADIOTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ARMORACIA RUSTICANA;

EID: 67650569263     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.021     Document Type: Article

References (39)

1. Nix P., Cawkwell L., Patmore H., Greenman J., and Stafford N. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br. J. Cancer 92 (2005) 2185-2189
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics. Ca. Cancer J. Clin. 58 (2008) 71-96
3. Andry G., Hamoir M., and Leemans C.R. The evolving role of surgery in the management of head and neck tumors. Curr. Opin. Oncol. 17 (2005) 241-248
4. Merlano M., Vitale V., Rosso R., Benasso M., Corvo R., Cavallari M., Sanguineti G., Bacigalupo A., Badellino F., Margarino G., et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. New Engl. J. Med. 327 (1992) 1115-1121
5. Greco O., Dachs G.U., Tozer G.M., and Kanthou C. Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy. J. Cell Biochem. 87 (2002) 221-232
6. Greco O., Folkes L.K., Wardman P., Tozer G.M., and Dachs G.U. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene. Ther. 7 (2000) 1414-1420
7. Tupper J., Greco O., Tozer G.M., and Dachs G.U. Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor model. Cancer Gene. Ther. 11 (2004) 508-513
8. Kobayashi S., Sugioka K., Nakano M., Takyu C., Yamagishi A., and Inaba H. Excitation of indole acetate in myeloperoxidase-H2O2 system: possible formation of indole acetate cation radical. Biochem. Biophys. Res. Commun. 93 (1980) 967-973
9. Folkes L.K., Candeias L.P., and Wardman P. Toward targeted "oxidation therapy" of cancer: peroxidase-catalysed cytotoxicity of indole-3-acetic acids. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 917-920
10. Wirth T., Kuhnel F., and Kubicka S. Telomerase-dependent gene therapy. Curr. Mol. Med. 5 (2005) 243-251
11. Fakhoury J., Nimmo G.A., and Autexier C. Harnessing telomerase in cancer therapeutics. Anticancer Agents Med. Chem. 7 (2007) 475-483
12. Almadori G., Bussu F., Cadoni G., Galli J., Paludetti G., and Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur. J. Cancer 41 (2005) 683-693
13. Hohaus S., Cavallo S., Bellacosa A., Genuardi M., Galli J., Cadoni G., Almadori G., Lauriola L., Litwin S., Maurizi M., and Neri G. Telomerase activity in human laryngeal squamous cell carcinomas. Clin. Cancer Res. 2 (1996) 1895-1900
14. Luzar B., Poljak M., Marin I.J., Fischinger J., and Gale N. Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas. Anticancer Res. 21 (2001) 4011-4015
15. Gu J., and Fang B. Telomerase promoter-driven cancer gene therapy. Cancer Biol. Ther. 2 (2003) S64-S70
16. Keith W.N., Bilsland A., Hardie M., and Evans T.R. Drug insight: cancer cell immortality-telomerase as a target for novel cancer gene therapies. Nat. Clin. Pract. Oncol. 1 (2004) 88-96
17. Liao Z.K., Zhou F.X., Luo Z.G., Zhang W.J., Xiong J., Bao J., Han G., Zhang M.S., Xie C.H., and Zhou Y.F. Radio-activation of hTERT promoter in larynx squamous carcinoma cells: an 'indirected-activator' strategy in radio-gene-therapy. Oncol. Rep. 19 (2008) 281-286
18. Zhong Y.H., Liao Z.K., Zhou F.X., Xie C.H., Xiao C.Y., Pan D.F., Luo Z.G., Liu S.Q., and Zhou Y.F. Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background. Biochem. Biophys. Res. Commun. 367 (2008) 84-89
19. F.X. Zhou, J. Xiong, Z.G. Luo, J. Dai, H.J. Yu, Z.K. Liao, Z. Cao, C.H. Xie, Y.F. Zhou, Human radiosensitive-radioresistant cell line model and its cDNA expression profiles. Rad. Res. (2009) RR1657. (in revision).
20. Horikawa I., Cable P.L., Mazur S.J., Appella E., Afshari C.A., and Barrett J.C. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol. Biol. Cell. 13 (2002) 2585-2597
21. Connolly C.N., Futter C.E., Gibson A., Hopkins C.R., and Cutler D.F. Transport into and out of the Golgi complex studied by transfecting cells with cDNAs encoding horseradish peroxidase. J. Cell Biol. 127 (1994) 641-652
22. Hoffman R.M. In vitro sensitivity assays in cancer: a review, analysis, and prognosis. J. Clin. Lab. Anal. 5 (1991) 133-143
23. Dachs G.U., Tupper J., and Tozer G.M. From bench to bedside for gene-directed enzyme prodrug therapy of cancer. Anticancer Drugs 16 (2005) 349-359
24. de Melo M.P., de Lima T.M., Pithon-Curi T.C., and Curi R. The mechanism of indole acetic acid cytotoxicity. Toxicol. Lett. 148 (2004) 103-111
25. Kim D.S., Jeon S.E., Jeong Y.M., Kim S.Y., Kwon S.B., and Park K.C. Hydrogen peroxide is a mediator of indole-3-acetic acid/horseradish peroxidase-induced apoptosis. FEBS Lett. 580 (2006) 1439-1446
26. Steel G.G., McMillan T.J., and Peacock J.H. The 5Rs of radiobiology. Int. J. Radiat. Biol. 56 (1989) 1045-1048
27. Joiner M.C., Lambin P., Malaise E.P., Robson T., Arrand J.E., Skov K.A., and Marples B. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat. Res. 358 (1996) 171-183
28. Britten R.A., Evans A.J., Allalunis-Turner M.J., Franko A.J., and Pearcey R.G. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother. Oncol. 39 (1996) 145-153
29. Kaliberov S.A., Market J.M., Gillespie G.Y., Krendelchtchikova V., Della Manna D., Sellers J.C., Kaliberova L.N., Black M.E., and Buchsbaum D.J. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene. Ther. 14 (2007) 1111-1119
30. Ogawa Y., Nishioka A., Hamada N., Terashima M., Inomata T., Yoshida S., Seguchi H., and Kishimoto S. Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome. Int. J. Mol. Med. 2 (1998) 301-307
31. Sawant S.G., Gregoire V., Dhar S., Umbricht C.B., Cvilic S., Sukumar S., and Pandita T.K. Telomerase activity as a measure for monitoring radiocurability of tumor cells. Faseb J. 13 (1999) 1047-1054
32. Curran A.J., Gullane P.J., Irish J., Macmillan C., Freeman J., and Kamel-Reid S. Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope 110 (2000) 391-396
33. Hande M.P., Lansdorp P.M., and Natarajan A.T. Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing. Mutat. Res. 404 (1998) 205-214
34. Hauguel T., and Bunz F. Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells. Cancer Biol. Ther. 2 (2003) 679-684
35. Zhou F.X., Liao Z.K., Dai J., Xiong J., Xie C.H., Luo Z.G., Liu S.Q., and Zhou Y.F. Radiosensitization effect of zidovudine on human malignant glioma cells. Biochem. Biophys. Res. Commun. 354 (2007) 351-356
36. Kim J.K., Choi S.H., Kim C.O., Park J.S., Ahn W.S., and Kim C.K. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency. J. Pharm. Pharmacol. 55 (2003) 453-460
37. Wen S.Y., Wang X.H., Lin L., Guan W., and Wang S.Q. Preparation and property analysis of a hepatocyte targeting pH-sensitive liposome. World J. Gastroenterol. 10 (2004) 244-249
38. Stevens C.W., Zeng M., and Cerniglia G.J. Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum. Gene. Ther. 7 (1996) 1727-1734
39. Zhang M., Li S., Li J., Ensminger W.D., and Lawrence T.S. Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts. Mol. Ther. 8 (2003) 21-28